BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32967974)

  • 1. A stepped-wedge randomized trial and qualitative survey of HIV pre-exposure prophylaxis uptake in the Eswatini population.
    Geldsetzer P; Bärnighausen K; Hettema A; McMahon SA; Dalal S; Chase RP; Oldenburg CE; Kohler S; Chen S; Dlamini P; Mavuso M; Hughey AB; Matse S; Bärnighausen T
    Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32967974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We know this will be hard at the beginning, but better in the long term": understanding PrEP uptake in the general population in Eswatini.
    Bärnighausen K; Matse S; Hughey AB; Hettema A; Bärnighausen TW; McMahon SA
    AIDS Care; 2020 Feb; 32(2):267-273. PubMed ID: 31437021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini.
    Inghels M; Kim HY; Tanser F; Hettema A; McMahon SA; Oldenburg CE; Matse S; Kohler S; Geldsetzer P; Bärnighausen T
    AIDS Behav; 2022 Oct; 26(10):3345-3355. PubMed ID: 35429309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative accounts of PrEP discontinuation from the general population in Eswatini.
    Bärnighausen K; Geldsetzer P; Matse S; Hettema A; Hughey AB; Dlamini P; Mavuso M; Fakudze D; Kahn K; Bärnighausen T; McMahon SA
    Cult Health Sex; 2021 Sep; 23(9):1198-1214. PubMed ID: 32633617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human resource needs and costs for HIV pre-exposure prophylaxis provision in nurse-led primary care in Eswatini and opportunities for task sharing.
    Kohler S; Dalal S; Hettema A; Matse S; Bärnighausen T; Paul N
    Hum Resour Health; 2022 Oct; 20(1):75. PubMed ID: 36274118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'This is mine, this is for me': preexposure prophylaxis as a source of resilience among women in Eswatini.
    Bärnighausen KE; Matse S; Kennedy CE; Lejeune CL; Hughey AB; Hettema A; Bärnighausen TW; McMahon SA
    AIDS; 2019 Jun; 33 Suppl 1():S45-S52. PubMed ID: 31397722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini.
    Berner-Rodoreda A; Geldsetzer P; Bärnighausen K; Hettema A; Bärnighausen T; Matse S; McMahon SA
    PLoS One; 2020; 15(9):e0237427. PubMed ID: 32966307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
    Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Donnell D; Baeten JM;
    J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM; Hanif H; Anderson SM; Clark MR; Gustafson K; Doncel GF
    AIDS Behav; 2024 Mar; 28(3):936-950. PubMed ID: 37971614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review.
    Mpirirwe R; Segawa I; Ojiambo KO; Kamacooko O; Nangendo J; Semitala FC; Kyambadde P; Kalyango JN; Kiragga A; Karamagi C; Katahoire A; Kamya M; Mujugira A
    BMJ Open; 2024 Apr; 14(4):e076545. PubMed ID: 38670600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa.
    Busang J; Zuma T; Herbst C; Okesola N; Chimbindi N; Dreyer J; Mtshali N; Smit T; Ngubane S; Hlongwane S; Gumede D; Jalazi A; Mdluli S; Bird K; Msane S; Danisa P; Hanekom W; Lebina L; Behuhuma N; Hendrickson C; Miot J; Seeley J; Harling G; Jarolimova J; Sherr L; Copas A; Baisley K; Shahmanesh M
    BMC Public Health; 2023 Aug; 23(1):1553. PubMed ID: 37582746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Service delivery models that promote linkages to PrEP for adolescent girls and young women and men in sub-Saharan Africa: a scoping review.
    Ramraj T; Chirinda W; Jonas K; Govindasamy D; Jama N; McClinton Appollis T; Zani B; Mukumbang FC; Basera W; Hlongwa M; Turawa EB; Mathews C; Nicol E
    BMJ Open; 2023 Mar; 13(3):e061503. PubMed ID: 36972966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.